Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03033654
Other study ID # H-1-2014-094
Secondary ID
Status Completed
Phase N/A
First received January 20, 2017
Last updated January 26, 2017
Start date February 2015
Est. completion date February 2015

Study information

Verified date January 2017
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators aim to investigate how much two consecutive applications of sunscreen before sun exposure can increase the quantities of sunscreen applied and decrease the skin area left without sunscreen compared to a single application. Volunteers wearing swimwear applied sunscreen in a laboratory environment twice and had pictures taken in black light before and after. As sunscreens absorb black light the darkness of the skin increased with increasing amounts of sunscreen applied. The investigators conducted a standard curve establishing a link between picture darkness and applied sunscreen quantity. Participants were asked to apply sunscreen the way they would normally do but two consecutive times. No other advice was given. The level of protection was determined by picture analysis as measurements of darkness of selected skin sites as well as the percentages of skin area left without sunscreen in different body regions and in total.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date February 2015
Est. primary completion date February 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Healthy Caucasians between older than 18

Exclusion Criteria:

- Suffering from a skin disease, were allergic to the content in sunscreen, were pregnant or breastfeeding

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Sunscreen, Actinica
Two Consecutive Sunscreen Applications

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Bispebjerg Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Sun protection Sun protection will be determined as sunscreen quantities applied in mg/cm^2 and areas of covered skin in percentage. The day of intervention. Sun protection will be assessed right after sunscreen application.
See also
  Status Clinical Trial Phase
Completed NCT02376517 - Helping All Children be Safe Outdoors With Sun Protection N/A
Completed NCT02952235 - Evaluation of Sunscreens Under Actual Use Conditions N/A
Completed NCT03344796 - UV Exposure Assessed With Wearable Sensor and Sun Protection N/A
Completed NCT02177006 - Helping Children be Safe Outdoors With Sun Protection
Completed NCT01001975 - Determination of Sun Protection in Sunscreen Formulas (Study SR09-15)(P08236)(COMPLETED) Phase 3